No Data
No Data
CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares
A Quick Look at Today's Ratings for Pyxis Oncology(PYXS.US), With a Forecast Between $7 to $10
Institutional Investors in Pyxis Oncology, Inc. (NASDAQ:PYXS) See US$130m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care
No Data
No Data